Nosocomial outbreak caused by multidrug-resistant Pseudomonas aeruginosa producing IMP-13 metallo-beta-lactamase

Laura Pagani1, Céline Colinon, Roberta Migliavacca

  • 1Dipartimento di Scienze Morfologiche, Eidologiche e Cliniche, Sezione di Microbiologia, Università di Pavia, Italy.

Insights

A multidrug-resistant Pseudomonas aeruginosa outbreak in an Italian ICU involved 15 patients. The outbreak was linked to the bla(IMP-13) gene and resolved with improved infection control.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Hospital Epidemiology

Background:

  • Nosocomial outbreaks of multidrug-resistant (MDR) Pseudomonas aeruginosa pose significant challenges in intensive care units (ICUs).
  • The emergence of metallo-beta-lactamase (MBL) producing pathogens is a growing global health concern.

Purpose of the Study:

  • To investigate a 5-month outbreak of MDR Pseudomonas aeruginosa in a general ICU.
  • To characterize the molecular mechanisms and genetic elements responsible for the observed multidrug resistance.

Main Methods:

  • Analysis of 87 P. aeruginosa isolates from 15 patients using phenotypic resistance testing, metallo-beta-lactamase activity assays, and pulsed-field gel electrophoresis (PFGE) for genotyping.
  • Molecular analysis of resistance genes, including sequencing of the MBL determinant and associated genetic elements.

Main Results:

  • The outbreak involved 15 patients and was caused by a clonal strain of P. aeruginosa exhibiting resistance to carbapenems, ceftazidime, cefepime, gentamicin, tobramycin, and fluoroquinolones.
  • Isolates produced metallo-beta-lactamase (MBL) activity due to the bla(IMP-13) gene located on a class 1 integron, alongside an aminoglycoside resistance cassette.
  • The bla(IMP-13) gene was chromosomally located and not transferable by conjugation; its genetic environment resembled previously reported IMP-13 isolates from Rome.

Conclusions:

  • This study reports the first significant nosocomial outbreak in Europe caused by an IMP-13 producing P. aeruginosa.
  • The outbreak coincided with nursing staff shortages and was resolved by reinforcing infection control measures and reinstating nursing personnel.
  • Effective infection control practices and adequate staffing are crucial for managing MDR pathogen outbreaks in ICUs.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...